SelectQuote Q1 2027 Earnings Call Transcript

Nov 4, 2026, 9:29 AM ETResultsRead the original at Benzinga

Good for SLQT

SelectQuote cut its adjusted EBITDA loss by more than $15 million and lifted trailing 12-month adjusted EBITDA 30%. Sales fell 15%, but stronger profit and cash flow results make the report favorable overall.

SLQT · SelectQuote

AI read · Good for SLQT

The AI's read

The stronger adjusted results suggest SelectQuote is earning more from its operations despite selling less. Its cash flow beat expectations, and profit per SelectRx member rose 60% from the previous year. The sales decline remains a concern. The company linked it to health care law changes and cautious hiring, so the stronger profit results do not erase the weaker sales.

Get alerts for SLQT

Follow SelectQuote (SLQT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SLQT

Free on the App Store and Google Play, or on the web.